Vitaliana De Sanctis | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
The impact of healthy lifestyles on late sequelae in classical hodgkin lymphoma and diffuse large b-cell lymphoma survivors. A systematic review by the fondazione italiana linfomi	CANCERS	2021
The role of radiation therapy technologist in interventional radiotherapy (brachytherapy) in Italy: Italian Association of Radiotherapy and Clinical Oncology (AIRO) and Italian Association of Radiation Therapy and Medical Physics Technologists (AITRO) joint project	JOURNAL OF CONTEMPORARY BRACHYTHERAPY	2021
A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations	CLINICAL & TRANSLATIONAL ONCOLOGY	2021
Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study	CLINICAL BREAST CANCER	2021
Stereotactic and hypofractionated radiotherapy associated with immune checkpoint inhibitor drugs: Analysis of local control, toxicity, and outcome in a single research centre case study	ANTICANCER RESEARCH	2021
Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer	FRONTIERS IN ONCOLOGY	2021
Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study	CANCER TREATMENT AND RESEARCH COMMUNICATIONS	2021
Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy	CANCER DIAGNOSIS & PROGNOSIS	2021
Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic – A document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group	RADIOTHERAPY AND ONCOLOGY	2020
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study	IN VIVO	2020
One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients	JOURNAL OF CONTEMPORARY BRACHYTHERAPY	2020
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum	RADIATION ONCOLOGY	2020
The role of vaginal brachytherapy in stage I endometrial serous cancer. a systematic review	JOURNAL OF CONTEMPORARY BRACHYTHERAPY	2020
Can brachytherapy be properly considered in the clinical practice? Trilogy project. The vision of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy study group	JOURNAL OF CONTEMPORARY BRACHYTHERAPY	2020
Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study	CLINICAL BREAST CANCER	2020
The role of palliative interventional radiotherapy (brachytherapy) in esophageal cancer. An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review focused on dysphagia-free survival	BRACHYTHERAPY	2020
Interacts (INTErventional Radiotherapy ACtive Teaching School) consensus conference on sarcoma interventional radiotherapy (brachytherapy) endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology)	JOURNAL OF CONTEMPORARY BRACHYTHERAPY	2020
Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer	SCIENTIFIC REPORTS	2020
Post-mastectomy immediate breast reconstruction and adjuvant radiotherapy: long term results of a mono institutional experience	LA RADIOLOGIA MEDICA	2020
The role of interventional radiotherapy (brachytherapy) in stage i esophageal cancer: An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES	2020

Progetti di Ricerca

Ruolo del Regorafenib come opzione terapeutica di II linea nelle recidive di glioblastoma: valutazione dei benefici nei pazienti già sottoposti a trattamento radioterapico e chemioterapico con temozolomide.
Impatto della moderna radioterapia sulla sopravvivenza dei pazienti con diagnosi di linfoma (Hodgkin e non Hodgkin) diagnosticati nella Regione Lazio dal 2013 al 2017: un modello epidemiologico real-life.